Back to News
research

This "Magnificent Seven" Stock Could Be the Biggest Winner in 2026, According to Wall Street

The Motley Fool
Loading...
6 min read
1 views
0 likes
This "Magnificent Seven" Stock Could Be the Biggest Winner in 2026, According to Wall Street

Summarize this article with:

By Keith Speights – Dec 15, 2025 at 4:44AM ESTKey PointsAnalysts project one big loser and two laggards among the "Magnificent Seven" stocks next year.Wall Street expects the other four stocks in the group to deliver strong gains in 2026.Analysts think that one "Magnificent Seven" stock could soar 39% over the next 12 months.These 10 Stocks Could Mint the Next Wave of Millionaires ›NASDAQ: AAPLAppleMarket Cap$4.1TToday's Changeangle-down(0.09%) $0.25Current Price$278.28Price as of December 12, 2025 at 4:00 PM ETWall Street's favorite "Magnificent Seven" stock for 2026 has already been a big winner in 2025.No one has Nostradamus-like powers of prediction. That's true even of Nostradamus himself, whose track record wasn't nearly as impressive as the hype surrounding some of his prophecies. That said, Wall Street analysts are paid handsomely to thoroughly research stocks, enabling them to attempt to project how the stocks might perform in the near term. Unsurprisingly, many analysts focus on the so-called "Magnificent Seven" stocks, since they rank among the largest stocks on the market. One member of the elite group could be the biggest winner in 2026, according to Wall Street. Image source: Getty Images. Losers and laggards Before we get to Wall Street's projected biggest winner among the Magnificent Seven, let's look at a few that analysts believe will be losers and laggards. Tesla (TSLA +2.70%) will be the biggest loser next year, if analysts are right. Less than half of the 47 analysts surveyed by S&P Global (SPGI +0.70%) in December rated Tesla as a "buy" or "strong buy." The average 12-month price target for the electric vehicle maker is 12% below the share price as of the market close on Dec. 11, 2025. Wall Street doesn't seem to think Apple's (AAPL +0.09%) recent momentum has legs, either. Although 29 of the 48 analysts surveyed by S&P Global recommended the iPhone maker's stock as a "buy" or "strong buy," the consensus price target for Apple reflects minimal upside potential.Advertisement ExpandNASDAQ: AAPLAppleToday's Change(0.09%) $0.25Current Price$278.28Key Data PointsMarket Cap$4.1TDay's Range$276.82 - $279.2252wk Range$169.21 - $288.62Volume10KAvg Vol49MGross Margin46.91%Dividend Yield0.37% It's a similar story for Alphabet (GOOG 1.03%) (GOOGL 1.03%). Google's parent company is popular on Wall Street, with 56 of the 65 analysts surveyed by S&P Global rating the stock as a "buy" or better. However, the average 12-month price target for Alphabet is only 5% above its share price. Wall Street's winners Wall Street doesn't think all of the Magnificent Seven stocks will be duds in 2026, though. Analysts expect several members of the group to be significant winners in the new year. For example, the consensus price target for Amazon (AMZN 1.80%) reflects an upside potential of roughly 28% over the next 12 months. Such a gain would be a nice improvement over Amazon's lackluster performance this year. Impressively, 64 of the 67 analysts surveyed by S&P Global rated Amazon as a "buy" or "strong buy," with the three outliers recommending holding the stock. ExpandNASDAQ: AMZNAmazonToday's Change(-1.80%) $-4.15Current Price$226.13Key Data PointsMarket Cap$2.4TDay's Range$225.13 - $230.2152wk Range$161.38 - $258.60Volume1.4MAvg Vol48MGross Margin50.05% Analysts think Meta Platforms' (META 1.30%) share price will soar around the same amount as Amazon's. Support for the parent company of Facebook and Instagram was also broad, with 60 of the 67 analysts surveyed by S&P Global rating the stock as a "buy" or better. Wall Street also loves Microsoft (MSFT 1.02%). The average 12-month price target is around 29% higher than the share price as of the market close on Dec. 11, 2025. Fifty-four of the 56 analysts surveyed by S&P Global recommend Microsoft as a "buy" or "strong buy." The most magnificent of all? If you're familiar with the Magnificent Seven stocks, you know that only one remains that hasn't been mentioned so far: Nvidia (NVDA 3.30%). Wall Street appears to view the GPU maker as the most magnificent of them all. ExpandNASDAQ: NVDANvidiaToday's Change(-3.30%) $-5.97Current Price$174.96Key Data PointsMarket Cap$4.3TDay's Range$174.62 - $182.8152wk Range$86.62 - $212.19Volume6.2MAvg Vol191MGross Margin70.05%Dividend Yield0.02% The consensus price target for Nvidia reflects an upside potential of 39%. Of the 64 analysts surveyed by S&P Global, 60 rated the stock as a "buy" or better. I think Wall Street's bullish take on Nvidia is warranted. The AI boom is likely to continue in 2026 as organizations scramble to implement agentic AI solutions, in my opinion. Although the competition in the AI chip market may intensify, I expect Nvidia's GPUs to enjoy strong demand. Optimism about the prospects for Amazon, Meta, and Microsoft also makes sense to me. Amazon and Microsoft should, like Nvidia, benefit from an agentic AI tailwind. Meta is reportedly cutting costs in its metaverse unit, which should boost profitability. However, I suspect that analysts may be wrong about the growth potential for Alphabet and Apple next year. Google Cloud is firing on all cylinders and is likely to continue doing so in 2026. Apple's iPhone 17 is experiencing strong sales momentum as 2025 comes to a close. Also, I expect both Google and Apple will unveil smart glasses next year that could compete with the Ray-Ban Meta AI glasses. What about Tesla? I won't even try to predict whether or not the stock will decline as much as Wall Street thinks it will. After all, I'm no Nostradamus.About the AuthorKeith Speights is a contributing Motley Fool healthcare analyst covering publicly traded companies across pharmaceuticals, biotechnology, medical devices, technology, and marijuana. Prior to The Motley Fool, Keith was CEO of Constant Care Technology, a healthcare technology company; vice president of American HealthTech, a healthcare software company; and a director of operations for Blue Cross Blue Shield of Mississippi, a health insurer. He holds a B.S. in Industrial Engineering from Mississippi State University.TMFFishBizRead NextDec 13, 2025 •By Keith SpeightsThese 3 Warren Buffett AI Stocks Could Be Big Winners in 2026Dec 12, 2025 •By Danny Vena, CPAPrediction: This Could Be the World's Most Valuable Stock in 2026, According to 1 Wall Street Analyst (Hint: Not Nvidia)Dec 9, 2025 •By Adria CiminoThis Tech Company is One of the Largest by Market Capitalization.

But Is Its Stock a Buy?Dec 6, 2025 •By Daniel SparksHere's Why Apple Is My Second Biggest Holding Going Into 2026Dec 5, 2025 •By Sean WilliamsBillionaire Warren Buffett Has Over $75 Billion Invested in 3 "Magnificent" Artificial Intelligence (AI) StocksDec 3, 2025 •By Daniel SparksHere's My Top "Magnificent Seven" Stock Pick for 2026

Read Original

Source Information

Source: The Motley Fool